firstwordpharmaAugust 20, 2021
Tag: COVID-19 , Vaccine , Delta variant
As various debates continue around current and future COVID-19 vaccine adoption we are fielding a new snap poll to US-based infectious disease specialists to capture their views on a number of key questions…
Reports indicate that the FDA will fully approve Pfizer’s COVID-19 vaccine by early September. Do you think full approval will help to meaningfully combat vaccine hesitancy?
Are you confident that current partial and full vaccination rates in the US will significantly reduce impact from the current ‘Delta variant’ wave of infections, as measured in terms of hospitalisation and death rates?
Do you advocate use of third-dose ‘booster’ vaccine shots this fall/winter?
Which of the following long-term scenarios do you think is the most likely regarding future COVID-19 vaccine use for the majority of people?
Which of the following long-term scenarios do you think is the most likely regarding future COVID-19 vaccine use for the ‘at risk’ population?
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: